CL2022000902A1 - Virus del moquillo canino hemaglutinina y polipéptidos de fusión - Google Patents

Virus del moquillo canino hemaglutinina y polipéptidos de fusión

Info

Publication number
CL2022000902A1
CL2022000902A1 CL2022000902A CL2022000902A CL2022000902A1 CL 2022000902 A1 CL2022000902 A1 CL 2022000902A1 CL 2022000902 A CL2022000902 A CL 2022000902A CL 2022000902 A CL2022000902 A CL 2022000902A CL 2022000902 A1 CL2022000902 A1 CL 2022000902A1
Authority
CL
Chile
Prior art keywords
fusion polypeptides
canine distemper
distemper virus
virus haemagglutinin
haemagglutinin
Prior art date
Application number
CL2022000902A
Other languages
English (en)
Inventor
Stephen James Russell
Alia Miguel A Munoz
Original Assignee
Mayo Found Medical Education & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Found Medical Education & Res filed Critical Mayo Found Medical Education & Res
Publication of CL2022000902A1 publication Critical patent/CL2022000902A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/766—Rhabdovirus, e.g. vesicular stomatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2887—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
    • C12N2760/20232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
    • C12N2760/20241—Use of virus, viral particle or viral elements as a vector
    • C12N2760/20243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
CL2022000902A 2019-10-09 2022-04-08 Virus del moquillo canino hemaglutinina y polipéptidos de fusión CL2022000902A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962913111P 2019-10-09 2019-10-09

Publications (1)

Publication Number Publication Date
CL2022000902A1 true CL2022000902A1 (es) 2023-04-21

Family

ID=75437513

Family Applications (3)

Application Number Title Priority Date Filing Date
CL2022000902A CL2022000902A1 (es) 2019-10-09 2022-04-08 Virus del moquillo canino hemaglutinina y polipéptidos de fusión
CL2024002011A CL2024002011A1 (es) 2019-10-09 2024-07-01 Virus del moquillo canino, composición; y uso.
CL2024002582A CL2024002582A1 (es) 2019-10-09 2024-08-29 Polipéptidos f y h del virus del moquillo canino (cdv), composición; y uso.

Family Applications After (2)

Application Number Title Priority Date Filing Date
CL2024002011A CL2024002011A1 (es) 2019-10-09 2024-07-01 Virus del moquillo canino, composición; y uso.
CL2024002582A CL2024002582A1 (es) 2019-10-09 2024-08-29 Polipéptidos f y h del virus del moquillo canino (cdv), composición; y uso.

Country Status (16)

Country Link
US (1) US20240066081A1 (es)
EP (1) EP4041752A4 (es)
JP (1) JP2022551486A (es)
KR (1) KR20220079607A (es)
CN (1) CN115605497A (es)
AU (1) AU2020364084A1 (es)
BR (1) BR112022006578A2 (es)
CA (1) CA3156935A1 (es)
CL (3) CL2022000902A1 (es)
CO (1) CO2022004984A2 (es)
IL (1) IL291968A (es)
MX (1) MX2022004384A (es)
PE (1) PE20221166A1 (es)
PH (1) PH12022550836A1 (es)
WO (1) WO2021072284A2 (es)
ZA (1) ZA202203974B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020086939A1 (en) * 2018-10-26 2020-04-30 The Wistar Institute Of Anatomy And Biology Canine distemper vaccines and methods of treatment using the same
EP4298228A4 (en) * 2021-02-23 2025-09-24 Mayo Found Medical Education & Res Genetically engineered hemagglutinin and fusion polypeptides from canine distemper virus
CO2021017322A1 (es) * 2021-12-16 2023-06-20 Univ Cooperativa De Colombia Péptidos inmunogénicos contra el virus distemper canino (cdv)
KR20260005359A (ko) * 2023-04-27 2026-01-09 밀테니 비오텍 비.브이. & 씨오. 케이지 개 디스템퍼 바이러스의 외피 단백질로 슈도타이핑된 레트로바이러스 벡터 입자
EP4501946A1 (en) * 2023-07-31 2025-02-05 LoopLab Bio GmbH Self-amplifying biologics for targeted therapy
CN120290491A (zh) * 2025-06-05 2025-07-11 浙江农林大学 一株杂交瘤细胞株、犬瘟热病毒h蛋白单克隆抗体和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2375320C (en) * 1999-06-10 2013-02-19 Merial Dna vaccines for pets or for animals used in sports
EP1549672B1 (en) * 2002-05-03 2010-09-01 Mayo Foundation For Medical Education And Research Ablated slam-dependent cell entry
WO2013158263A1 (en) * 2012-04-18 2013-10-24 Mayo Foundation For Medical Education And Research Replication-competent vesicular stomatitis viruses
EP3625349B1 (en) * 2017-05-16 2024-08-28 Mayo Foundation for Medical Education and Research Modified viruses
EP3679129A1 (en) * 2017-09-05 2020-07-15 GLAdiator Biosciences, Inc. A method of intracellular delivery

Also Published As

Publication number Publication date
WO2021072284A3 (en) 2021-05-20
CN115605497A (zh) 2023-01-13
JP2022551486A (ja) 2022-12-09
IL291968A (en) 2022-06-01
CL2024002011A1 (es) 2024-12-20
EP4041752A4 (en) 2024-03-20
CA3156935A1 (en) 2021-04-15
PH12022550836A1 (en) 2023-10-09
BR112022006578A2 (pt) 2022-06-28
PE20221166A1 (es) 2022-07-25
ZA202203974B (en) 2025-10-29
CL2024002582A1 (es) 2024-12-20
WO2021072284A9 (en) 2022-04-28
US20240066081A1 (en) 2024-02-29
KR20220079607A (ko) 2022-06-13
WO2021072284A2 (en) 2021-04-15
CO2022004984A2 (es) 2022-04-29
EP4041752A2 (en) 2022-08-17
MX2022004384A (es) 2022-08-08
AU2020364084A1 (en) 2022-04-21

Similar Documents

Publication Publication Date Title
CL2022000902A1 (es) Virus del moquillo canino hemaglutinina y polipéptidos de fusión
IL282985B (en) Modified oncolytic viurs
EP3731850A4 (en) ONCOLYTIC VIRUS DELIVERY OF THERAPEUTIC POLYPEPTIDES
IL262652A (en) Gdf15 fusion proteins and uses thereof
EP3820887A4 (en) Pd1-4-1bbl variant fusion protein and methods of use thereof
IL254165B (en) Immunomodulatory fusion proteins and uses thereof
HRP20251571T1 (hr) Rekombinantni virus humane/goveđe parainfluence 3 (b/hpiv3) koji eksprimira kimerični protein rsv/bpiv3 f i njegove uporabe
IL292625A (en) Viruses with modified capsid proteins
EP3943503A4 (en) Adeno-associated virus having variant capsid protein and use thereof
EP3489354A4 (en) RECOMBINANT VACCINIA VIRUS AND USE THEREOF
DK3768305T3 (da) Modificerede, onkolytiske adenovira
EP3518947C0 (en) OPTIMIZED ONCOLYTIC VIRUSES AND USES THEREOF
EP3950720A4 (en) Fusion protein and use thereof
EP4190906C0 (en) MODIFIED POLYPEPTIDES DERIVED FROM ADENOVIRAL FIBER PROTEIN AND VLPS CONTAINING POLYPEPTIDES
KR20180084995A (ko) Fmdv 및 e2 융합 단백질 및 이의 용도
EP3917995A4 (en) PROTEIN-COATED MATERIALS
EP3573632C0 (en) TUMOR-SELECTIVE TATA BOX AND CAAT BOX MUTANT ONCOLYTIC VIRUSES
EP4041256A4 (en) Oncolytic viruses that express multi-specific immune cell engagers
IL263990A (en) Fusion protein between short form rod-derived cone viability factor and a hydrophilic peptide
EP3365005C0 (en) MOPEIA RECOMBINANT VIRUS AND VACCINE PLATFORM
EP3625349A4 (en) MODIFIED VIRUSES
EP3810164A4 (en) ANTIGENIC DISGUISED ONCOLYTIC VIRUSES
EP4055034A4 (en) Viral capsid polypeptides
EP3789489A4 (en) ANTI-SWEEPER TYPE ONCOLYTIC VIRUS
EP3624825A4 (en) RECOMBINANT ONCOLYTIC VIRUS